Press Contact

If you would like to find out more about Abiomed® and the Impella® heart pumps, or if you have any questions, please do not hesitate to contact us.


Dr. Sebastian Heindrichs

Associate Director European Communications
Neuenhofer Weg 3 | 52074 Aachen,  Germany
E-Mail: sheindrichs(at)
Phone: +49 (0)151 7447 2278

Press Releases

January 7, 2021

Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents

December 21, 2020

First Patients, Including a COVID-19 Patient, Treated with Abiomed’s Innovative ECMO Technology

December 15, 2020

Two Milestones Achieved Toward Small Bore Access with Impella

November 5, 2020

First 1,000 Patients Treated with Impella 5.5 with SmartAssist, a Heart Pump Designed for Surgeons

October 28, 2020

First Patients Treated with the World’s Smallest Heart Pump, the 9Fr Impella ECP

October 26, 2020

FDA Grants 510(k) Clearance for Abiomed’s Innovative Cardiopulmonary Support Technology

October 16, 2020

Data Presented at TCT Connect Finds Pre-PCI Use of Impella for AMI Cardiogenic Shock is Associated with Higher Survival, Particularly in Women

October 16, 2020

Studies Presented at TCT Connect Associate Higher Survival With Early Identification of Right Heart Failure and Early Use of Impella RP

October 15, 2020

Largest Study of Hemodynamically Supported High-Risk PCI Patients Finds More Complete Revascularization with Impella Leads to Improved Outcomes

October 14, 2020

Restore EF Study Demonstrates Impella-Supported High-Risk PCI Improves Left Ventricular Ejection Fraction

October 8, 2020

TCT Connect to Highlight How Impella Enables Improved Outcomes for High-Risk PCI, Cardiogenic Shock and Right Heart Failure Patients

July 30, 2020

Large Multi-Center Study in Japan Finds High Survival Rates with Use of Impella Heart Pump
PDF Download

July 1, 2020

Study Finds 84% Survival Rate in Patients in Cardiogenic Shock and Other Challenging Cardiac Conditions with the New Impella 5.5 with SmartAssist
PDF Download

June 16, 2020

Abiomed Launches Virtual Physician Education Program, CAMP PCI, to Improve High-Risk PCI Patient Outcomes
PDF Download

June 5, 2020

FDA Approves Abiomed’s First-in-Human Trial of Impella ECP, World’s Smallest Heart Pump
PDF Download

May 19, 2020

PROTECT III Study Shows Placing Impella Prior to High-Risk PCI is Associated with Lower Mortality Compared to Bailout PCI
PDF Download

April 29, 2020

Abiomed Expands Product Portfolio with Acquisition of Cardiopulmonary Support Technology (ECMO) to Improve Outcomes for Patients
PDF Download

May 21, 2019

National Cardiogenic Shock Initiative (NCSI) with Impella Best Practices Demonstrates 72% Survival with 98% Native Heart Recovery

PDF Download

April 4, 2019

Cardiogenic Shock Survival Rates Improve Significantly in Three Years Since Impella FDA PMA Approval

PDF Download